Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Advanced Solid Tumor 13Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 7Advanced Solid Tumors 7Breast Neoplasms 6Solid Tumor 5Pancreatic Neoplasms 5Melanoma 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4Neoplasms 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Solid Tumors 3Recurrence 3Myelodysplastic Syndromes 3Lung Neoplasms 3Leukemia, Biphenotypic, Acute 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Advanced Malignant Solid Tumor 3Advanced Lung Cancer 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Cyclophosphamide 4blinatumomab 3Azacitidine 3venetoclax 2tetrathiomolybdate 1tagraxofusp 1siremadlin 1sabatolimab 1posaconazole 1pembrolizumab 1midostaurin 1fludarabine phosphate 1fludarabine 1daratumumab 1avelumab 1aflutinib 1Whole-Body Irradiation 1Sirolimus 1Mycophenolic Acid 1Monatide (IMS 3015) 1Midazolam 1Melphalan 1Injections 1Idarubicin 1Daunorubicin 1Cytarabine 1Celecoxib 1Capecitabine 1Biological Assay 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasm, Residual × Injections × Clear all
NCT04707300 2025-11-20

HTLP-ONCO

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Recruiting
10 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡